We are live on
!
Find out more
DHFB
Dixon Hubard Feinour & Brown Portfolio holdings
AUM
$842M
1-Year Est. Return
2.74%
This Fund
S&P 500
This Quarter
Est. Return
-11.95%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$270M
AUM Growth
-$91.5M
(-25%)
Cap. Flow
-$47.5M
Cap. Flow
% of AUM
-17.6%
Top 10 Holdings %
Top 10 Hldgs %
29.27%
Holding
186
New
6
Increased
34
Reduced
74
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$7.06M |
| 2 |
UnitedHealth
UNH
|
+$6.09M |
| 3 |
Zoetis
ZTS
|
+$5.52M |
| 4 |
Ulta Beauty
ULTA
|
+$3.73M |
| 5 |
Verizon
VZ
|
+$479K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$7.85M |
| 2 |
Phillips 66
PSX
|
+$7.78M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$7.68M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$7.42M |
| 5 |
Cintas
CTAS
|
+$7.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.65% |
| 2 | Technology | 17.48% |
| 3 | Financials | 9.53% |
| 4 | Industrials | 8.75% |
| 5 | Consumer Discretionary | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.84T
| $10.5M | 3.88% |
103,054
-1,268
| -1% | -$136K |
|
2
Apple
AAPL
$4.89T
| $10.4M | 3.85% |
263,832
+5,180
| +2% | +$251K |
|
3
PayPal
PYPL
$49.5B
| $8.19M | 3.03% |
97,411
-1,824
| -2% | -$152K |
|
4
Stryker
SYK
$127B
| $7.92M | 2.93% |
50,498
-600
| -1% | -$100K |
|
5
Thermo Fisher Scientific
TMO
$211B
| $7.62M | 2.82% |
34,043
-1,072
| -3% | -$252K |
|
|
6
Zoetis
ZTS
$31.6B
| $7.24M | 2.68% |
84,660
+61,270
| +262% | +$5.52M |
|
|
7
Edwards Lifesciences
EW
$47.6B
| $7.12M | 2.64% |
+139,536
| New | +$7.06M |
|
8
Home Depot
HD
$332B
| $6.84M | 2.53% |
39,830
-925
| -2% | -$166K |
|
9
Adobe
ADBE
$89.5B
| $6.66M | 2.47% |
29,430
-590
| -2% | -$142K |
|
10
Zebra Technologies
ZBRA
$12.4B
| $6.58M | 2.44% |
41,340
-270
| -0.6% | -$45K |
|
11
Pfizer
PFE
$140B
| $6.25M | 2.31% |
150,934
+1,408
| +0.9% | +$58.4K |
|
12
Alphabet (Google) Class C
GOOG
$3.9T
| $5.98M | 2.21% |
115,440
-800
| -0.7% | -$42.8K |
|
|
13
UnitedHealth
UNH
$382B
| $5.94M | 2.2% |
23,845
+23,045
| +2,881% | +$6.09M |
|
14
Global Payments
GPN
$22.1B
| $5.68M | 2.1% |
55,109
-790
| -1% | -$87K |
|
15
Johnson & Johnson
JNJ
$635B
| $5.46M | 2.02% |
42,308
+1,234
| +3% | +$172K |
|
|
WCG
16
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.43M | 2.01% |
23,000
-325
| -1% | -$87.1K |
|
17
FedEx
FDX
$74.5B
| $4.79M | 1.78% |
29,720
-1,470
| -5% | -$311K |
|
18
ExxonMobil
XOM
$651B
| $4.73M | 1.75% |
69,425
-5,277
| -7% | -$414K |
|
|
19
Alphabet (Google) Class A
GOOGL
$3.91T
| $4.35M | 1.61% |
83,200
-1,340
| -2% | -$72.4K |
|
20
ServiceNow
NOW
$102B
| $4.27M | 1.58% |
119,875
-30,950
| -21% | -$1.1M |
|
21
Norfolk Southern
NSC
$78.8B
| $4.2M | 1.56% |
28,102
+43
| +0.2% | +$7.07K |
|
22
Williams-Sonoma
WSM
$26.7B
| $3.76M | 1.39% |
148,920
-38,180
| -20% | -$1.09M |
|
23
Cisco
CSCO
$450B
| $3.55M | 1.31% |
81,851
+8,304
| +11% | +$380K |
|
|
24
Ulta Beauty
ULTA
$20.4B
| $3.31M | 1.23% |
+13,512
| New | +$3.73M |
|
25
Alibaba
BABA
$269B
| $3.27M | 1.21% |
23,846
-2,772
| -10% | -$410K |
|
Similar funds
BDWM
MCM
TFM
MWM
CP
BWM
FPS
IC
Dixon Hubard Feinour & Brown's Q4 2018 Portfolio in Review
As of Q4 2018, Dixon Hubard Feinour & Brown held 186 positions worth $270M, down 25% from $362M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Dixon Hubard Feinour & Brown withdrew a net $47.5M in Q4 2018, closing 23 positions and reducing 74 holdings. Its most notable exit was Amphenol, an estimated $7.85M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, Dixon Hubard Feinour & Brown opened a new position in Edwards Lifesciences worth $7.12M.
- Dixon Hubard Feinour & Brown's largest Q4 2018 buy was Edwards Lifesciences: 139,536 shares worth $7.12M.
- Dixon Hubard Feinour & Brown added most to UnitedHealth in Q4 2018, an estimated $6.09M increase.
- Dixon Hubard Feinour & Brown's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $7.68M.
- Dixon Hubard Feinour & Brown fully exited Amphenol in Q4 2018, selling an estimated $7.85M.
- Dixon Hubard Feinour & Brown's ten largest holdings make up 29% of its $270M portfolio in Q4 2018.
- Dixon Hubard Feinour & Brown opened 6 new positions and closed 23 in Q4 2018.
- Dixon Hubard Feinour & Brown's portfolio value fell 25% quarter-over-quarter to $270M.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q4 2018, filed 13 Feb 2019.